Investing Profile

Barbara Dalton

VCInvestor
Senior Managing Partner at Pfizer Venture Investments
pfizer.com/partnering/areas_o...New York, New York
Photo of Barbara Dalton, Vice President at Pfizer Venture Investments
Your Intro Paths to Barbara Dalton

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Barbara Dalton on

cb
Current Investing Position
Pfizer Venture Investments Vice President
Investment Range
$100K - $15.0M
Sweet Spot
$10.0M
Investments On Record
8

Barbara Dalton is on these Sector & Stage Rankings

Barbara Dalton's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Artios Pharma
Series CJul 2021$150M
Series BAug 2018$83M
$270M
Co-investors: Hakan Goker (M Ventures (Merck)), René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners)
Complexa
Series CJul 2017$62M
$62M
Co-investors: Ven Raju (Innovation Works), Peter Erin (Innovation Works), Sara Nayeem (Avoro Ventures)
Ixchelsis
Series UnknownDec 2016$12M
$12M
Cydan
Series UnknownApr 2013$16M
$60M
Co-investors: David Mott (Mott Family Capital)
Rhythm Pharmaceuticals
Series BNov 2012$33M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Steven St. Peter (T1D Fund)
Ablexis
Series AJun 2010$12M
$12M
Co-investors: Lou Tartaglia (Cure Ventures), Cary Pfeffer (Third Rock Ventures)
Flexion Therapeutics
Series AJan 2010$9M
$62M
Co-investors: Andrew Schwab (5am Ventures), Heath Lukatch (Red Tree Venture Capital)